Selected article for: "pneumococcal vaccine and polysaccharide pneumococcal vaccine"

Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
  • ID: t9tysvr8_71
    Snippet: No potential conflict of interest relevant to this article was reported. HSCT, hematopoietic stem cell transplantation. a Following the three doses of 13-valent pneumococcal conjugate vaccine (PCV), a dose of 23-valent polysaccharide pneumococcal vaccine may be given to broaden the covered spectrum. In HSCT recipients with chronic graft-versus-host disease (GVHD) who are likely to respond poorly to polysaccharide vaccine, a fourth PCV should be c.....
    Document: No potential conflict of interest relevant to this article was reported. HSCT, hematopoietic stem cell transplantation. a Following the three doses of 13-valent pneumococcal conjugate vaccine (PCV), a dose of 23-valent polysaccharide pneumococcal vaccine may be given to broaden the covered spectrum. In HSCT recipients with chronic graft-versus-host disease (GVHD) who are likely to respond poorly to polysaccharide vaccine, a fourth PCV should be considered at intervals of more than 6 months.

    Search related documents:
    Co phrase search for related documents